会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications
    • 用至少一个疏水基团官能化的聚氨基酸及其应用特别是治疗应用
    • US20070010652A1
    • 2007-01-11
    • US10558617
    • 2004-05-28
    • Stephanie AngotOlivier BreyneYou-Ping Chan
    • Stephanie AngotOlivier BreyneYou-Ping Chan
    • C08G69/10
    • A61K8/88A61K47/645A61K2800/57A61Q19/00C08G69/10C08G69/48
    • The invention relates to novel materials based on biodegradable polyamino acids, particularly useful for the vectorisation of active principals (PA). The invention further relates to novel, pharmaceutical, cosmetic, dietary or phytosanitary compositions based on said polyamino acids. The aim of the invention is to provide a novel polymeric raw material, for use in the vectorisation of PA and with an optimal match for all the requirements of the type: biocompatibility, biodegradability, stability, ability to easily associate with numerous active principals or to solubilise the same and to liberate said active principals in vivo. Said aim is achieved with polyamino acids comprising aspartic and/or glutamate units, some of which carry at least one graft, characterised in that at least one of said grafts is bonded to an aspartic or glutamate unit by means of an amino acids spacer based on Leu, and/or Ileu, and/or Val, and/or Phe and a hydrophobic group with C6-C30 is connected by an ester bond to the spacer. Said specific amino acid spacers guarantee an improved stability to hydrolysis and a higher association quotient with proteins when compared with conventional analogous products. Said polymers have the advantage of easily and economically being transformed into vectorisation particles for active principals said particles being themselves able to form stable aqueous colloidal suspensions.
    • 本发明涉及基于可生物降解的聚氨基酸的新型材料,特别适用于活性成分(PA)的向量化。 本发明进一步涉及基于所述聚氨基酸的新型药物,化妆品,膳食或植物检疫组合物。 本发明的目的是提供一种新型的聚合物原料,用于PA的向量化,并具有与以下类型的所有要求的最佳匹配:生物相容性,生物可降解性,稳定性,容易与许多活性成分相关的能力或 溶解相同并在体内释放所述活性成分。 所述目的通过包含天冬氨酸和/或谷氨酸单体的聚氨基酸实现,其中一些氨基酸携带至少一个接枝物,其特征在于至少一个所述移植物通过氨基酸间隔基与天冬氨酸或谷氨酸单元结合,基于 Leu和/或Ileu和/或Val,和/或Phe和具有C6-C30的疏水基团通过酯键连接到间隔物上。 当与常规类似产物相比时,所述特异性氨基酸间隔物保证了水解的稳定性提高和与蛋白质的较高缔合商。 所述聚合物具有容易且经济地转化成用于活性原料的载体化颗粒的优点,所述颗粒本身能够形成稳定的水性胶体悬浮液。
    • 14. 发明申请
    • Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications
    • 由具有阴离子电荷的疏水性接枝物官能化的聚氨基酸及其应用,例如治疗应用
    • US20100098656A1
    • 2010-04-22
    • US11658803
    • 2005-07-25
    • Olivier BreyneGauthier PouliquenYou-Ping Chan
    • Olivier BreyneGauthier PouliquenYou-Ping Chan
    • A61K38/16C07K2/00A61K38/18A61K38/20A61K38/21
    • C08G69/10A61K8/88A61K2800/57A61Q19/00C08G69/48
    • The present invention relates to novel materials based on biodegradable polyamino acids that are useful especially for the vectorization of active principle(s) (AP). The invention further relates to novel pharmaceutical, cosmetic, dietetic or phytosanitary compositions based on these polyamino acids. The object of the invention is to provide a novel polymer starting material that is capable of being used for the vectorization of AP and makes it possible on the one hand to achieve high polymer/AP ratios, and on the other hand optimally to satisfy all the specifications required in the case in point: biocompatibility, biodegradability, ability to associate easily with numerous active principles or to solubilize them, and ability to release these active principles in vivo. This object is achieved by the present invention, which relates first and foremost to linear polyamino acids comprising aspartic units or glutamic units and having hydrophobic grafts comprising hydrophobic groups containing from 8 to 30 carbon atoms, at least one of these hydrophobic grafts having at least one anionic charge and/or one or more mutually identical or different ionizable groups each capable of giving rise to at least one anionic charge. These polymers are amphiphilic and anionic and are capable of being converted easily and economically to particles for the vectorization of active principles, these particles themselves being capable of forming stable aqueous colloidal suspensions.
    • 本发明涉及基于可生物降解的聚氨基酸的新型材料,其特别用于活性成分(AP)的向量化。 本发明还涉及基于这些聚氨基酸的新型药物,化妆品,饮食或植物检疫组合物。 本发明的目的是提供一种新的聚合物起始材料,其能够用于AP的向量化,并且一方面可以实现高聚合物/ AP比率,另一方面最佳地满足所有 在这种情况下需要的规格:生物相容性,生物降解能力,容易与许多活性成分缔合或溶解它们的能力以及在体内释放这些活性成分的能力。 该目的通过本发明来实现,本发明首先涉及包含天冬氨酸单元或谷氨酸单元并具有包含含有8至30个碳原子的疏水基团的疏水性接枝的线性聚氨基酸,这些疏水性移植物中的至少一种具有至少一个 阴离子电荷和/或一个或多个相互相同或不同的可离子化基团,每个基团能够产生至少一种阴离子电荷。 这些聚合物是两亲性和阴离子性的,并且能够容易地和经济地转化成用于活性成分载体化的颗粒,这些颗粒本身能够形成稳定的水性胶态悬浮液。
    • 15. 发明授权
    • Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
    • 由α-生育酚功能化的聚氨基酸及其用途,特别用于治疗应用
    • US07683024B2
    • 2010-03-23
    • US10516733
    • 2003-06-03
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • C07K38/02
    • A61K8/88A61K8/678A61K9/5146A61K47/34A61K2800/57A61Q19/00C08G69/10C08G69/48
    • The invention concerns novel biodegradable polyaminoacid materials, useful in particular for vectoring active principle(s). The invention also concerns novel pharmaceutical, cosmetic dietetic or phytosanitary compositions based on said polyaminoacids. The invention aims at providing a novel polymer raw material, capable of being used for vectoring active principles and enabling optimal fulfillment of all specified requirements: biocompatibility, biodegradability, easy and inexpensive transformation into particles vectoring active principles, the particles being themselves capable of forming colloidal suspensions, of being easily associated with numerous active principles, and of releasing said active principles in vivo. Therefor, the present invention concerns first of all amphiphilic polyaminoacids comprising aspartic acid units and/or glutamic acid units, characterized in that at least part of said units carry grafts, including at least one alpha-tocopherol motif, for example (polyglutamate or polyaspartate grafted with alpha-tocopherol of synthetic or natural origin).
    • 本发明涉及新型可生物降解的聚氨基酸材料,特别适用于向量活性成分。 本发明还涉及基于所述聚氨基酸的新型药物,美容饮食或植物检疫组合物。 本发明旨在提供一种新颖的聚合物原料,能够用于向导活性原理,并能够最佳地实现所有特定的要求:生物相容性,生物降解性,易于和便宜地转化成粒子的载体活性成分,颗粒本身能够形成胶体 悬浮液,易于与许多活性成分相关联,并且在体内释放所述活性成分。 因此,本发明涉及包含天冬氨酸单元和/或谷氨酸单元的所有两亲性聚氨基酸的首要问题,其特征在于所述单元的至少一部分携带移植物,包括至少一种α-生育酚基序,例如(聚谷氨酸或聚天冬氨酸嫁接 合成或天然来源的α-生育酚)。
    • 16. 发明授权
    • Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof
    • 由至少一个疏水基团官能化的聚氨基酸及其治疗应用
    • US07678882B2
    • 2010-03-16
    • US11509783
    • 2006-08-25
    • Stéphanie AngotOlivier BreyneYou-Ping ChanGérard Soula
    • Stéphanie AngotOlivier BreyneYou-Ping ChanGérard Soula
    • C07K2/00
    • A61Q19/00A61K8/88A61K47/34A61K47/645A61K47/65C08G69/10C08G69/48
    • The invention relates to novel materials based on biodegradable polyamino acids that are useful for vectorizing active principle(s)(AP). The aim of the invention is to supply a new polymeric raw material that is used for vectorizing AP and optimally fulfills all requirements concerning biocompatibility, biodegradability, the ability to be easily associated with numerous active principles or solubilize the active principles and to release the active principles in vivo. Such polymers can also be readily and economically transformed into particles vectorizing active principles according to the grafting rate of the hydrophobic groups, said particles being able to form stable aqueous colloidal suspensions. The aim of the invention is achieved by the inventive amphiphile polyamino acids comprising aspartic and/or glutamic units that carry grafts which encompass at least one hydrophobic unit and are linked to the aspartic and/or glutamic units via a rotula containing two amide functions, more particularly via a spacer of the lysine or ornithine type. The amide functions ensure better stability during hydrolysis than comparable products known in prior art. The invention also relates to new pharmaceutical, cosmetic, dietetic, or phytosanitary compositions based on the inventive polyamino acids.
    • 本发明涉及可用于向量化活性成分(AP)的可生物降解的聚氨基酸的新型材料。 本发明的目的是提供一种新的聚合物原料,其用于向AP进行载体化,并且最佳地满足关于生物相容性,生物可降解性,易于与许多活性成分相关联或增溶活性成分的能力的所有要求,并释放活性成分 体内。 这样的聚合物也可以容易地和经济地转化成根据疏水基团的接枝速率向量化活性成分的颗粒,所述颗粒能够形成稳定的水性胶态悬浮液。 本发明的目的是通过包含天冬氨酸和/或谷氨酸单元的本发明的两亲性聚氨基酸实现的,所述天然氨基酸和/或谷氨酸单元携带包含至少一个疏水单元的移植物,并通过含有两个酰胺官能团的转运体与天冬氨酸和/或谷氨酸单元连接 特别是通过赖氨酸或鸟氨酸类型的间隔物。 酰胺功能确保在水解期间比现有技术中已知的可比产品更好的稳定性。 本发明还涉及基于本发明的聚氨基酸的新的药物,化妆品,饮食或植物检疫组合物。
    • 17. 发明申请
    • POLYAMINOACIDS FUNCTIONALIZED WTIH ALPHA-TOCOPHEROL, AND USES THEREOF, ESPECIALLY THERAPEUTIC USES
    • 聚氨基甲酸酯功能性维生素A和其用途,特别是治疗用途
    • US20100048735A1
    • 2010-02-25
    • US12581644
    • 2009-10-19
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • A61K47/34C08G73/10A61P43/00
    • A61K8/88A61K8/678A61K9/5146A61K47/34A61K2800/57A61Q19/00C08G69/10C08G69/48
    • The invention concerns novel biodegradable polyaminoacid materials, useful in particular for vectoring active principles(s). The invention also concerns novel pharmaceutical, cosmetic dietetic or phytosanitary compositions based on said polyaminoacids. The invention aims at providing a novel polymer raw material, capable of being used for vectoring active principles and enabling optimal fulfillment of all specified requirements: biocompatibility, biodegradability, easy and inexpensive transformation into particles vectoring active principles, said particles being themselves capable of forming colloidal suspensions, of being easily associated with numerous active principles, and of releasing said active principles in vivo. Therefor, the present invention concerns first of all amphiphilic polyaminoacids comprising aspartic acid units and/or glutamic acid units, characterized in that at least part of said units carry grafts, including at least one alphα-tocopherol motif, for example (polyglutamate or polyaspartate grafted with alphα-tocopherol of synthetic or natural origin).
    • 本发明涉及新颖的可生物降解的聚氨基酸材料,特别适用于载体活​​性成分。 本发明还涉及基于所述聚氨基酸的新型药物,美容饮食或植物检疫组合物。 本发明旨在提供一种新颖的聚合物原料,其能够用于向量活性成分的原理并且能够最佳地实现所有特定的要求:生物相容性,生物降解性,容易且便宜的转化成粒子的载体活性成分,所述颗粒本身能够形成胶体 悬浮液,易于与许多活性成分相关联,并且在体内释放所述活性成分。 因此,本发明涉及包含天冬氨酸单元和/或谷氨酸单元的所有两亲性聚氨基酸的首要问题,其特征在于至少部分所述单元携带移植物,包括至少一种α-α-生育酚基序,例如(聚谷氨酸或聚天冬氨酸酯接枝 合成或天然来源的α-生育酚)。
    • 18. 发明申请
    • Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof
    • 聚电解质的改性释放颗粒及其药物制剂
    • US20090011039A1
    • 2009-01-08
    • US12149552
    • 2008-05-05
    • Cecile Bonnet-GonnetFrederic ChecotYou-Ping ChanOlivier Breyne
    • Cecile Bonnet-GonnetFrederic ChecotYou-Ping ChanOlivier Breyne
    • A61K47/30A61K9/14
    • A61K9/5146A61K9/1641
    • The present invention relates to novel particles comprising polyelectrolyte polymers which are transporters of active principle (AP), in particular protein and peptide active principle, and to novel modified-release pharmaceutical formulations comprising said AP microparticles.These novel particles loaded with AP release the AP over a prolonged period of time of several days, or even several weeks.The invention relates, in a first aspect, to particles comprising: a) a first polyelectrolyte polymer (PE1) in a charged state, carrying side hydrophobic groups (GH), wherein said first polyelectrolyte polymer (PE1) can spontaneously form, in water, a colloidal solution of particles at least one pHm value of the pH of between 3 and 8; b) a second polyelectrolyte polymer (PE2) of opposite polarity to the first polyelectrolyte polymer (PE1), wherein said second polyelectrolyte polymer (PE2) forms, in water, a solution or a colloidal solution at said pHm value of the pH; and c) at least one active principle (AP) associated noncovalently with the particles of the colloidal solution of the first polyelectrolyte polymer (PE1); wherein said particles are obtained by mixing, at a pH equal to pHm, the first polyelectrolyte polymer (PE1), in the form of a colloidal solution of particles associated with the active principle (AP), with the second polyelectrolyte polymer (PE2), in the form of a solution or colloidal solution. The invention also relates to the process for the preparation of these particles, to a pharmaceutical formulation comprising such particles and to a process for the preparation of medicaments.
    • 本发明涉及包含聚电解质聚合物的新型颗粒,其为活性成分(AP)的转运体,特别是蛋白质和肽活性成分,以及包含所述AP微粒的新型改性释放药物制剂。 装载AP的这些新型颗粒在几天甚至几周的较长时间内释放AP。 本发明在第一方面涉及包含以下的颗粒:a)带电状态的第一聚电解质聚合物(PE1),其携带侧疏水基团(GH),其中所述第一聚电解质聚合物(PE1)可在水中自发形成, 颗粒的胶体溶液,其pH值在3至8之间的至少一个pHm值; b)与第一聚电解质聚合物(PE1)相反极性的第二聚电解质聚合物(PE2),其中所述第二聚电解质聚合物(PE2)在水中以所述pHm的pH值在水中形成溶液或胶体溶液; 和c)与第一聚电解质聚合物(PE1)的胶体溶液的颗粒非共价结合的至少一种活性成分(AP); 其中所述颗粒是通过在等于pHm的pH下,以与活性成分(AP)相关的颗粒的胶态溶液与第二聚电解质聚合物(PE2)的形式混合第一聚电解质聚合物(PE1)而获得的, 以溶液或胶体溶液的形式存在。 本发明还涉及制备这些颗粒的方法,包括这种颗粒的药物制剂和制备药物的方法。